Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
Key facts
- Where
- Bad Berka, Bad Krozingen, Cottbus, and Münster, GermanySee the 4 sites
Where in Germany
- Zentralklinik Bad BerckaBad Berka, GermanyContact: Ahmad KelaniTaking people
- Uniklinik FreiburgBad Krozingen, GermanyContact: Heiko LehrmannTaking people
- Carl-Thiem-KlinikumCottbus, GermanyContact: Dirk Grosse MeininghausTaking people
- Universitätsklinikum MünsterMünster, GermanyContact: Lars EckardtTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT07777744
- Record updated
- 20 August 2026
- Original description
The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.Read full original descriptionShow less
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation - an International Multicenter Collaborative Study Group
The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.
Inclusion: Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years; Patients: Females and males of >18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together; Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers; Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death; Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting; Length of follow-up: Peri-procedural complications; Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years; Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers.
Exclusion: Refusal of the center to participate; Less than 10 procedures available in the dataset (no case reports); Missing essential baseline characteristics, missing collection of sufficient details regarding each complication.